Kehua Biotech: Announcement on not revising the “Kehua Bonds” conversion price downward
Kehua Biotech: Announcement on financing financial institutions and providing guarantees for subsidiaries in 2025
Kehua Biotech: Announcement of Resolutions of the 11th Meeting of the 10th Board of Directors
Kehua Biotech: Joint Credit Assessment Co., Ltd.\'s concern announcement on the 2024 performance forecast loss of Shanghai Kehua Bioengineering Co., Ltd.
Kehua Biotech: An indicative announcement on “Kehua Bonds Transfer” which is expected to trigger a downward revision of the conversion price
Kehua Biotech: 2024 Annual Performance Forecast
Kehua Biotech: Announcement on the product obtaining a medical device registration certificate
Kehua Biotech: Announcement on the cancellation of shareholders\' share pledges
Kehua Biotech: Announcement on convertible debt-for-equity swaps in the fourth quarter of 2024
Kehua Biotech: Announcement on the product obtaining a medical device registration certificate
Kehua Biotech: Announcement on the product obtaining a medical device registration certificate
Kehua Biotech: Announcement on the progress of the repurchase of shares held by minority shareholders by the holding subsidiary Technogenetics S.P.A.
Kehua Biotech: Announcement on the product obtaining a medical device registration certificate
Kehua Biotech: Announcement on the product obtaining a medical device registration certificate
Kehua Biotech: Announcement on investing in the establishment of a subsidiary
Kehua Biotech: Announcement of Resolutions of the 10th Meeting of the 10th Board of Directors
Kehua Biotech: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Kehua Biotech: Legal Opinion of Beijing Jindu (Guangzhou) Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Shanghai Kehua Bioengineering Co., Ltd.
Kehua Biotech: Announcement on the product obtaining a medical device registration certificate
Kehua Biotech: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024